Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition

  • Bae, Ok-Nam (College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University) ;
  • Noh, Minsoo (Collge of Pharmacy, Natural Products Research Institute, Seoul National University) ;
  • Chun, Young-Jin (College of Pharmacy, Chung-Ang University) ;
  • Jeong, Tae Cheon (College of Pharmacy, Yeungnam University)
  • Received : 2014.09.16
  • Accepted : 2014.10.07
  • Published : 2015.01.01


Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed.



Supported by : Ministry of Food and Drug Safety


  1. Alitalo, A. K., Proulx, S. T., Karaman, S., Aebischer, D., Martino, S., Jost, M., Schneider, N., Bry, M. and Detmar, M. (2013) VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis. Cancer Res. 73, 4212-4221.
  2. Bernard, F. X., Morel, F., Camus, M., Pedretti, N., Barrault, C., Garnier, J. and Lecron, J. C. (2012) Keratinocytes under fire of proinflammatory cytokines: Bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis. J. Allergy (Cairo) 2012, 718725.
  3. Ballaun, C., Weninger, W., Uthman, A., Weich, H. and Tschachler, E. (1995) Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J. Invest. Dermatol. 104, 7-10.
  4. Bhushan, M., McLaughlin, B., Weiss, J. B. and Griffiths, C. E. (1999) Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br. J. Dermatol. 141, 1054-1060.
  5. Blaudschun, R., Brenneisen, P., Wlaschek, M., Meewes, C. and Scharffetter- Kochanek, K. (2000) The first peak of the UVB irradiationdependent biphasic induction of vascular endothelial growth factor (VEGF) is due to phosphorylation of the epidermal growth factor receptor and independent of autocrine transforming growth factor alpha. FEBS Lett. 474, 195-200.
  6. Brauchle, M., Funk, J. O., Kind, P. and Werner, S. (1996) Ultraviolet B and $H_{2}O_{2}$ are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 271, 21793-21797.
  7. Brenneisen, P., Blaudschun, R., Gille, J., Schneider, L., Hinrichs, R., Wlaschek, M., Eming, S. and Scharffetter-Kochanek, K. (2003) Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Biochem. J. 369, 341-349.
  8. Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F. and van de Water, L. (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375-1379.
  9. Canavese, M., Altruda, F., Ruzicka, T. and Schauber, J. (2010) Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis-- a possible target for novel therapies? J. Dermatol. Sci. 58, 171-176.
  10. Cao, Y., E, G., Wang, E., Pal, K., Dutta, S. K., Bar-Sagi, D. and Mukhopadhyay, D. (2012) VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. Cancer Res. 72, 3912-3918.
  11. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
  12. Christensen, T. E., Callis, K. P., Papenfuss, J., Hoffman, M. S., Hansen, C. B., Wong, B., Panko, J. M. and Krueger, G. G. (2006) Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes. J. Invest. Dermatol. 126, 2397-2403.
  13. Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G. and Levi, B. Z. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271, 736-741.
  14. de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N. and Williams, L. T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991.
  15. Detmar, M. (1996) Molecular regulation of angiogenesis in the skin. J. Invest. Dermatol. 106, 207-208.
  16. Detmar, M. (2000) The role of VEGF and thrombospondins in skin angiogenesis. J. Dermatol. Sci. 24 Suppl 1, S78-84.
  17. Detmar, M., Brown, L. F., Berse, B., Jackman, R. W., Elicker, B. M., Dvorak, H. F. and Claffey, K. P. (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Dermatol. 108, 263-268.
  18. Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B. and Dvorak, H. F. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141-1146.
  19. Detmar, M., Brown, L. F., Schon, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P. and Jain, R. K. (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111, 1-6.
  20. Detmar, M., Yeo, K. T., Nagy, J. A., Van de Water, L., Brown, L. F., Berse, B., Elicker, B. M., Ledbetter, S. and Dvorak, H. F. (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol. 105, 44-50.
  21. Diaz, B. V., Lenoir, M. C., Ladoux, A., Frelin, C., Demarchez, M. and Michel, S. (2000) Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J. Biol. Chem. 275, 642-650.
  22. Elias, P. M., Arbiser, J., Brown, B. E., Rossiter, H., Man, M. Q., Cerimele, F., Crumrine, D., Gunathilake, R., Choi, E. H., Uchida, Y., Tschachler, E. and Feingold, K. R. (2008) Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Am. J. Pathol. 173, 689-699.
  23. Enerback, C. (2011) Soluble biomarkers in psoriasis. Eur. J. Dermatol. 21, 844-850
  24. Ferrara, N., Gerber, H. P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
  25. Finkenzeller, G., Sparacio, A., Technau, A., Marme, D. and Siemeister, G. (1997) Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15, 669-676.
  26. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613.
  27. Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G. and Werner, S. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem. 270, 12607-12613.
  28. Geretti, E., Shimizu, A. and Klagsbrun, M. (2008) Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11, 31-39.
  29. Gille, J., Reisinger, K., Asbe-Vollkopf, A., Hardt-Weinelt, K. and Kaufmann, R. (2000) Ultraviolet-A-induced transactivation of the vascular endothelial growth factor gene in HaCaT keratinocytes is conveyed by activator protein-2 transcription factor. J. Invest. Dermatol. 115, 30-36.
  30. Gille, J., Swerlick, R. A. and Caughman, S. W. (1997) Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J. 16, 750-759.
  31. Goel, H. L. and Mercurio, A. M. (2013) VEGF targets the tumour cell. Nat. Rev. Cancer 13, 871-882.
  32. Hanel, K. H., Cornelissen C., Luscher, B. and Baron, J. M. (2013) Cytokines and the skin barrier. Int. J. Mol. Sci. 14, 6720-6745.
  33. Hicklin, D. J. and Ellis, L. M. (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23, 1011-1027.
  34. Hirakawa, S., Fujii, S., Kajiya, K., Yano, K. and Detmar, M. (2005) Vascular endothelial growth factor promotes sensitivity to ultraviolet Binduced cutaneous photodamage. Blood 105, 2392-2399.
  35. Huggenberger, R. and Detmar, M. (2011) The cutaneous vascular system in chronic skin inflammation. J. Investig. Dermatol. Symp. Proc. 15, 24-32.
  36. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K. and Alitalo, K. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425.
  37. Kakurai, M., Demitsu, T., Umemoto, N., Kobayashi, Y., Inoue-Narita, T., Fujita, N., Ohtsuki, M. and Furukawa, Y. (2009) Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes. Br. J. Dermatol. 161, 1232-1238.
  38. Karkkainen, M. J. and Petrova, T. V. (2000) Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19, 5598-5605.
  39. Kataru, R. P., Jung, K., Jang, C., Yang, H., Schwendener, R. A., Baik, J. E., Han, S. H., Alitalo, K. and Koh, G. Y. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113, 5650-5659.
  40. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J. and Connolly, D. T. (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.
  41. Kim, H. J. and Kim, T. Y. (2005) Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C. Br. J. Dermatol. 152, 418-425.
  42. Kozlowska, U., Blume-Peytavi, U., Kodelja, V., Sommer, C., Goerdt, S., Jablonska, S. and Orfanos, C. E. (1998) Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1 alpha, beta) in cells of the human pilosebaceous unit. Dermatology 196, 89-92.
  43. Kubo, A., Nagao, K. and Amagai, M. (2012) Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest. 122, 440-447.
  44. Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D. and Iruela-Arispe, M. L. (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691.
  45. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
  46. Longuet-Perret, I., Schmitt, D. and Viac, J. (1998) Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br. J. Dermatol. 138, 221-224.
  47. Ma, L., Xue, H. B., Guan, X. H., Shu, C. M., Zhang, J. H. and Yu, J. (2014) Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin. Exp. Immunol. 175, 25-31.
  48. Man, X. Y., Yang, X. H., Cai, S. Q., Bu, Z. Y. and Zheng, M. (2008) Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. J. Cell. Mol. Med. 12, 649-660.
  49. Man, X. Y., Yang, X. H., Cai, S. Q., Yao, Y. G. and Zheng, M. (2006) Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol. Med. 12, 127-136.
  50. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancerrelated inflammation. Nature 454, 436-444.
  51. Mildner, M., Weninger, W., Trautinger, F., Ban, J. and Tschachler, E. (1999) UVA and UVB radiation differentially regulate vascular endothelial growth factor expression in keratinocyte-derived cell lines and in human keratinocytes. Photochem. Photobiol. 70, 674-679.
  52. Nakai, K., Yoneda, K., Moriue, T., Igarashi, J., Kosaka, H. and Kubota, Y. (2009) HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells. J. Dermatol. Sci. 55, 170-178.
  53. Nielsen, H. J., Christensen, I. J., Svendsen, M. N., Hansen, U., Werther, K., Brunner, N., Petersen, L. J. and Kristensen, J. K. (2002) Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis. Inflamm. Res. 51, 563-567.
  54. Nissen, N. N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L. and DiPietro, L. A. (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol. 152, 1445-1452.
  55. Olsson, A. K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371.
  56. Palacio, S., Schmitt, D. and Viac, J. (1997) Contact allergens and sodium lauryl sulphate upregulate vascular endothelial growth factor in normal keratinocytes. Br. J. Dermatol. 137, 540-544.
  57. Quail, D. F. and Joyce, J. A. (2013) Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437.
  58. Rogers, M. S. and D'Amato, R. J. (2006) The effect of genetic diversity on angiogenesis. Exp. Cell Res. 312, 561-574.
  59. Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M. and Carmeliet, P. (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 89, 607-648.
  60. Schiefelbein, D., Seitz, O., Goren, I., Dissmann, J. P., Schmidt, H., Bachmann, M., Sader, R., Geisslinger, G., Pfeilschifter, J. and Frank, S. (2008) Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Mol. Pharmacol. 74, 952-963.
  61. Schonthaler, H. B., Huggenberger, R., Wculek, S. K., Detmar, M. and Wagner, E. F. (2009) Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc. Natl. Acad. Sci. U.S.A. 106, 21264-21269.
  62. Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H. and Arbeit, J. M. (2008) HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 111, 3343-3354.
  63. Sen, C. K., Khanna, S., Babior, B. M., Hunt, T. K., Ellison, E. C. and Roy, S. (2002) Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem. 277, 33284-33290.
  64. Senger, D. R. (2010) Vascular endothelial growth factor: much more than an angiogenesis factor. Mol. Biol. Cell 21, 377-379.
  65. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. and Dvorak, H. F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
  66. Shi, V. Y., Bao, L. and Chan, L. S. (2012) Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4- transgenic mouse model. Microcirculation 19, 567-579.
  67. Skobe, M., Brown, L. F., Tognazzi, K., Ganju, R. K., Dezube, B. J., Alitalo, K. and Detmar, M. (1999) Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDSassociated Kaposi's sarcoma. J. Invest. Dermatol. 113, 1047-1053.
  68. Suto, K., Yamazaki, Y., Morita, T. and Mizuno, H. (2005) Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J. Biol. Chem. 280, 2126-2131.
  69. Suzuki, T., Hirakawa, S., Shimauchi, T., Ito, T., Sakabe, J., Detmar, M. and Tokura, Y. (2014) VEGF-A promotes IL-17A-producing gammadelta T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells. J. Dermatol. Sci. 74, 116-124.
  70. Syed, D. N., Afaq, F. and Mukhtar, H. (2012) Differential activation of signaling pathways by UVA and UVB radiation in normal human epidermal keratinocytes. Photochem. Photobiol. 88, 1184-1190.
  71. Takahashi, H. and Shibuya, M. (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. (Lond) 109, 227-241.
  72. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C. and Abraham, J. A. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
  73. Trompezinski, S., Berthier-Vergnes, O., Denis, A., Schmitt, D. and Viac, J. (2004) Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts. Exp. Dermatol. 13, 98-105.
  74. Weidemann, A. K., Crawshaw, A. A., Byrne, E. and Young, H. S. (2013) Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin. Cosmet. Investig. Dermatol. 6, 233-244.
  75. Weir, L., Robertson, D., Leigh, I. M., Vass, J. K. and Panteleyev, A. A. (2011) Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes. Biochim. Biophys. Acta 1813, 60-72.
  76. Weninger, W., Uthman, A., Pammer, J., Pichler, A., Ballaun, C., Lang, I. M., Plettenberg, A., Bankl, H. C., Sturzl, M. and Tschachler, E. (1996) Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab. Invest. 75, 647-657.
  77. Wilgus, T. A., Matthies, A. M., Radek, K. A., Dovi, J. V., Burns, A. L., Shankar, R. and DiPietro, L. A. (2005) Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am. J. Pathol. 167, 1257-1266.
  78. Xia, Y. P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D. and Rudge, J. S. (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102, 161-168.
  79. Yano, K., Brown, L. F. and Detmar, M. (2001) Control of hair growth and follicle size by VEGF-mediated angiogenesis. J. Clin. Invest. 107, 409-417.
  80. Yano, K., Kadoya, K., Kajiya, K., Hong, Y. K. and Detmar, M. (2005) Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br. J. Dermatol. 152, 115-121.
  81. Young, H. S., Summers, A. M., Read, I. R., Fairhurst, D. A., Plant, D. J., Campalani, E., Smith, C. H., Barker, J. N., Detmar, M. J., Brenchley, P. E. and Griffiths, C. E. (2006) Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J. Invest. Dermatol. 126, 453-459.
  82. Yu, X. J., Ren, X. H., Xu, Y. H., Chen, L. M., Zhou, C. L., Li and C. Y. (2010) Vasoactive intestinal peptide induces vascular endothelial growth factor production in human HaCaT keratinocytes via MAPK pathway. Neuropeptides 44, 407-411.
  83. Zgraggen, S., Ochsenbein, A. M. and Detmar, M. (2013) An important role of blood and lymphatic vessels in inflammation and allergy. J. Allergy (Cairo) 2013, 672381.
  84. Zhang, Y., Matsuo, H. and Morita, E. (2006) Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis. Arch. Dermatol. Res. 297, 425-429.
  85. Zhu, J. W., Wu, X. J., Lu, Z. F., Luo, D., Cai, S. Q. and Zheng, M. (2013) Role of VEGF receptors in normal and psoriatic human keratinocytes: evidence from irradiation with different UV sources. PLoS One 8, e55463.
  86. Zhu, J. W., Wu, X. J., Luo, D., Lu, Z. F., Cai, S. Q. and Zheng, M. (2012) Activation of VEGFR-2 signaling in response to moderate dose of ultraviolet B promotes survival of normal human keratinocytes. Int. J. Biochem. Cell Biol. 44, 246-256.

Cited by

  1. Increased serum levels of vascular endothelial growth factor in pemphigus foliaceus patients with erythroderma vol.31, pp.2, 2017,
  2. Nesfatin-1 improves oxidative skin injury in normoglycemic or hyperglycemic rats vol.78, 2016,
  3. A newly synthesized macakurzin C-derivative attenuates acute and chronic skin inflammation: The Nrf2/heme oxygenase signaling as a potential target vol.307, 2016,
  4. Cystathionine metabolic enzymes play a role in the inflammation resolution of human keratinocytes in response to sub-cytotoxic formaldehyde exposure vol.310, 2016,
  5. Selective inhibition of JAK2/STAT1 signaling and iNOS expression mediates the anti-inflammatory effects of coniferyl aldehyde vol.256, 2016,
  6. Caffeic Acid Inhibits UVB-induced Inflammation and Photocarcinogenesis Through Activation of Peroxisome Proliferator-activated Receptor-γin Mouse Skin vol.91, pp.6, 2015,
  7. expression of vascular endothelial growth factor and endoglin in pemphigus foliaceus variants and pemphigus vulgaris pp.09269959, 2018,
  8. Leptin regulates the pro-inflammatory response in human epidermal keratinocytes vol.310, pp.4, 2018,
  9. Inhibitory Effects of a Novel Chrysin-Derivative, CPD 6, on Acute and Chronic Skin Inflammation vol.20, pp.11, 2019,
  10. Microfluidics-based skin irritation test using in vitro 3D angiogenesis platform vol.3, pp.3, 2015,
  11. Radiofrequency irradiation attenuates angiogenesis and inflammation in UVB‐induced rosacea in mouse skin vol.29, pp.7, 2015,
  12. Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis vol.8, pp.11, 2015,
  13. Effective lightening of facial melasma during the summer with a dual regimen: A prospective, open‐label, evaluator‐blinded study vol.19, pp.12, 2015,
  14. Hesperidin Inhibits UVB-Induced VEGF Production and Angiogenesis via the Inhibition of PI3K/Akt Pathway in HR-1 Hairless Mice vol.44, pp.10, 2015,
  15. A Fatty Acid Fraction Purified From Sea Buckthorn Seed Oil Has Regenerative Properties on Normal Skin Cells vol.12, pp.None, 2015,
  16. Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins vol.76, pp.4, 2021,